SOLUBLE LEVELS OF VEGF-A AND VEGFR-2 IN PATIENTS WITH ADVANCED NSCLC

被引：0
|
作者：
Sirera, R. [1 ]
Sanmartin, E. [2 ]
Jantus, E. [2 ]
Blasco, A. [3 ]
Caballero, C. [4 ]
Gallach, S. [2 ]
Olmo, P. [4 ]
del Pozo, N. [4 ]
Bremnes, R. M. [5 ]
Camps, C. [4 ]
机构：
[1] Univ Gen Hosp, Mol Oncol Lab, Valencia, Spain
[2] Hosp Gen Univ Valencia, Fdn Invest, Mol Oncol Lab, Valencia, Spain
[3] Cosorcio Hosp Gen Univ Valencia, Valencia, Spain
[4] Univ Gen Hosp Valencia, Oncol Serv, Valencia, Spain
[5] Univ Tromso, Inst Clin Med, Dept Oncol, Tromso, Norway
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [1] Plasma levels of VEGF-A and VEGFR-2 in advanced NSCLC
    Sanmartin, E.
    Jantus, E.
    Blasco, A.
    Sirera, R.
    Caballero, C.
    Gallach, S.
    Bremnes, R. M.
    del Pozo, N.
    Berrocal, A.
    Camps, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Combined VEGF-A and VEGFR-2 concentrations in plasma: Diagnostic and prognostic implications in patients with advanced NSCLC
    Jantus-Lewintre, Eloisa
    Sanmartin, Elena
    Sirera, Rafael
    Blasco, Ana
    Javier Sanchez, Jose
    Taron, Miguel
    Rosell, Rafael
    Camps, Carlos
    [J]. LUNG CANCER, 2011, 74 (02) : 326 - 331
  • [3] Association of plasma VEGF-A, soluble VEGFR-1 and VEGFR-2 levels and clinical response and survival in advanced colorectal cancer patients receiving bevacizumab with modified FOLFOX6
    Aoyagi, Yoshiko
    Iinuma, Hisae
    Horiuchi, Atsushi
    Shimada, Ryu
    Watanabe, Toshiaki
    [J]. ONCOLOGY LETTERS, 2010, 1 (02) : 253 - 259
  • [4] Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies
    Meng, Qian
    Shao, Li
    Luo, Xiucui
    Mu, Yingping
    Xu, Wen
    Gao, Li
    Xu, Haoqin
    Cui, Yugui
    [J]. REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2016, 14
  • [5] Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies
    Qian Meng
    Li Shao
    Xiucui Luo
    Yingping Mu
    Wen Xu
    Li Gao
    Haoqin Xu
    Yugui Cui
    [J]. Reproductive Biology and Endocrinology, 14
  • [6] Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors
    Pavlakovic, Helena
    Becker, Juergen
    Albuquerque, Romulo
    Wilting, Joerg
    Ambati, Jayakrishna
    [J]. LYMPHATICS IN THE DIGESTIVE SYSTEM: PHYSIOLOGY, HEALTH, AND DISEASE, 2010, 1207 : E7 - E15
  • [7] Ranibizumab interacts with the VEGF-A/VEGFR-2 signaling pathway in human RPE cells at different levels
    Ranjbar, Mahdy
    Brinkmann, Max Philipp
    Tura, Ayseguel
    Rudolf, Martin
    Miura, Yoko
    Grisanti, Salvatore
    [J]. CYTOKINE, 2016, 83 : 210 - 216
  • [8] VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants:: relationship to retinopathy of prematurity
    Pieh, C.
    Agostini, H.
    Buschbeck, C.
    Krueger, M.
    Schulte-Moenting, J.
    Zirrgiebel, U.
    Drevs, J.
    Lagreze, W. A.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (05) : 689 - 693
  • [9] Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma
    Nascimento, Catarina
    Gameiro, Andreia
    Ferreira, Joao
    Correia, Jorge
    Ferreira, Fernando
    [J]. CANCERS, 2021, 13 (01)
  • [10] Effect of laser photocoagulation on plasma levels of VEGF-A, VEGFR-2, and Tie2 in infants with retinopathy of prematurity
    Imamoglu, Ebru Yalin
    Gunay, Murat
    Gursoy, Tugba
    Imamoglu, Serhat
    Ekmekci, Ozlern Balci
    Celik, Gokhan
    Karatekin, Guner
    Ovali, Fahri
    [J]. JOURNAL OF AAPOS, 2014, 18 (05): : 466 - 470
12345